Pancreatic Cancer Research

ResearcherThe Christie HospitalActive in the last 2 years

Matthew Krebs

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0001-7540-3064; OpenAlex author ID A5080991347.

Their work

Papers
1
Trials
2 (principal investigator on 2)
Grants
0
Collaborators
3
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 trial · 2024: none · 2025: none · 2026: 1 trial

Papers 1

  1. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Co-author DOI 10.1038/bjc.2011.545↗

Trials 2

  1. DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Posit… Principal investigator NCT07440290↗
  2. DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Ampli… Principal investigator NCT05786716↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Caroline Dive · 1 shared paper, 2012
  2. Leila Khoja · 1 shared paper, 2012
  3. Juan W. Valle · 1 shared paper, 2012

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.